Timber Pharmaceuticals, Inc.
(NYSE Amex Equities : TMBR)

( )
TMBR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.43%166.860.7%$1081.06m
PFEPfizer Inc. -1.38%48.590.9%$912.26m
LLYEli Lilly & Co. 0.04%316.961.1%$820.24m
MRKMerck & Co., Inc. 0.42%91.420.7%$782.30m
ABBVAbbVie, Inc. -0.04%141.391.9%$776.62m
BMYBristol-Myers Squibb Co. -0.55%74.151.0%$614.48m
SIGASIGA Technologies, Inc. -6.42%23.180.0%$439.36m
AZNAstraZeneca Plc 0.12%66.501.0%$365.07m
GBTGlobal Blood Therapeutics, Inc. 0.08%67.055.6%$352.06m
GSKGSK Plc -0.17%34.250.3%$285.96m
ALNYAlnylam Pharmaceuticals, Inc. 0.14%223.458.2%$270.68m
HZNPHorizon Therapeutics Plc -0.84%61.215.4%$225.68m
CCXIChemoCentryx, Inc. 0.43%51.002.9%$213.70m
KRTXKaruna Therapeutics, Inc. -0.08%261.010.0%$204.69m
VERUVeru, Inc. -21.47%18.680.0%$196.18m

Company Profile

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.